Foundation Resource Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.03M Sell
159,173
-18,665
-10% -$861K 0.64% 41
2026
Q2
$8.53M Buy
177,838
+3,712
+2% +$159K 0.99% 37
2026
Q1
$6.4M Buy
174,126
+5,312
+3% +$252K 0.72% 40
2025
Q4
$8.59M Buy
168,814
+1,048
+0.6% +$53.6K 1.15% 28
2025
Q3
$9.31M Buy
+167,766
New +$9.8M 1.34% 26

Other funds holding NVO

Foundation Resource Management's NVO Position: Q3 2026 in Review

Foundation Resource Management reduced its Novo Nordisk (NVO) stake by 10% in Q3 2026, selling an estimated $861K and leaving 159,173 shares worth $6.03M. The position accounts for 0.64% of the portfolio, ranked #41.

Foundation Resource Management first reported a position in NVO in Q3 2025 and has held it in 5 quarters since. The position peaked at $9.31M in Q3 2025. 816 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Foundation Resource Management held 159,173 shares of Novo Nordisk worth $6.03M as of Q3 2026.
  • Foundation Resource Management sold 18,665 Novo Nordisk shares in Q3 2026, an estimated $861K.
  • Novo Nordisk made up 0.64% of Foundation Resource Management's portfolio in Q3 2026, its #41 holding.
  • Foundation Resource Management first reported a position in Novo Nordisk in Q3 2025 and has held it in 5 quarters since.
  • Foundation Resource Management's Novo Nordisk position peaked at $9.31M in Q3 2025.
  • 816 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Foundation Resource Management's 13F filing for Q3 2026, filed 19 Oct 2026.